Parsons Capital Management Inc Jounce Therapeutics, Inc. Transaction History

Parsons Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 28, 2021	SELL	$6.73 - $13.87 $72,791 - $150,017	-10,816 Closed	0 $0
Q2 2018 Aug 09, 2018	SELL	$7.27 - $21.88 $1,454 - $4,376	-200 Reduced 1.82%	10,816 $0
Q1 2018 May 07, 2018	SELL	$13.4 - $28.4 $428,800 - $908,800	-32,000 Reduced 74.39%	11,016 $246,000
Q3 2017 Oct 26, 2017	BUY	$11.17 - $16.99 $480,488 - $730,841	43,016	43,016 $670,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Parsons Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Parsons Capital Management Inc with notifications on news.